Basic Information
ABAC Therapeutics Develops New Targeted Antibiotics for Patients with Severe Infections, Enabling Precision Treatment of MDR Gram-Negative Bacterial Infections.
ABAC Therapeutics （ABAC）
Spain
less than 15 people
January 01, 2014
--